LCM
DTIL icon

Lynx1 Capital Management’s Precision BioSciences DTIL Stock Holding History

Lynx1 Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.42M Sell
985,113
-8,800
-0.9% -$40.6K 0.86% 10
2025
Q4 		$4.13M Sell
993,913
-48,683
-5% -$276K 0.84% 11
2025
Q3 		$5.76M Buy
1,042,596
+6,545
+0.6% +$31.3K 1.17% 8
2025
Q2 		$4.35M Buy
1,036,051
+270,000
+35% +$1.33M 1.26% 9
2025
Q1 		$3.65M Hold
766,051
– – 1.31% 9
2024
Q4 		$2.92M Buy
+766,051
New +$5.59M 1.09% 12

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Lynx1 Capital Management's DTIL Position: Q1 2026 in Review

Lynx1 Capital Management reduced its Precision BioSciences (DTIL) stake by 0.89% in Q1 2026, selling an estimated $40.6K and leaving 985,113 shares worth $5.42M. The position accounts for 0.86% of the portfolio, ranked #10.

Lynx1 Capital Management first reported a position in DTIL in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.76M in Q3 2025. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Lynx1 Capital Management held 985,113 shares of Precision BioSciences worth $5.42M as of Q1 2026.
  • Lynx1 Capital Management sold 8,800 Precision BioSciences shares in Q1 2026, an estimated $40.6K.
  • Precision BioSciences made up 0.86% of Lynx1 Capital Management's portfolio in Q1 2026, its #10 holding.
  • Lynx1 Capital Management first reported a position in Precision BioSciences in Q4 2024 and has held it in 6 quarters since.
  • Lynx1 Capital Management's Precision BioSciences position peaked at $5.76M in Q3 2025.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Lynx1 Capital Management's 13F filing for Q1 2026, filed 4 May 2026.